These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9634168)

  • 1. Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling.
    Rabinowitz J; Cohen H; Kotler M
    Psychiatr Serv; 1998 Jun; 49(6):831-3. PubMed ID: 9634168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification.
    Rabinowitz J; Cohen H; Atias S
    Am J Addict; 2002; 11(1):52-6. PubMed ID: 11876583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.
    Rabinowitz J; Cohen H; Tarrasch R; Kotler M
    Drug Alcohol Depend; 1997 Aug; 47(2):77-86. PubMed ID: 9298329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term relapse of ultra-rapid opioid detoxification.
    Salimi A; Safari F; Mohajerani SA; Hashemian M; Kolahi AA; Mottaghi K
    J Addict Dis; 2014; 33(1):33-40. PubMed ID: 24471478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrarapid opiate detoxification: a review.
    Kaye AD; Gevirtz C; Bosscher HA; Duke JB; Frost EA; Richards TA; Fields AM
    Can J Anaesth; 2003; 50(7):663-71. PubMed ID: 12944440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA; Sakhrani DL
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
    Cucchia AT; Monnat M; Spagnoli J; Ferrero F; Bertschy G
    Drug Alcohol Depend; 1998 Nov; 52(3):243-50. PubMed ID: 9839150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD).
    Albanese AP; Gevirtz C; Oppenheim B; Field JM; Abels I; Eustace JC
    J Addict Dis; 2000; 19(2):11-28. PubMed ID: 10809517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
    Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
    Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
    Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
    N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Carreño JE; Bobes J; Brewer C; Alvarez CE; San Narciso GI; Bascarán MT; Sánchez del Río J
    Addict Biol; 2002 Apr; 7(2):243-50. PubMed ID: 12006220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Opioid detoxication under general anesthesia].
    Zemtsovski MJ; Trosko O; Schmidt H
    Ugeskr Laeger; 2002 Sep; 164(36):4165-9. PubMed ID: 12362827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with clonidine-naltrexone for rapid opiate detoxification.
    Senft RA
    J Subst Abuse Treat; 1991; 8(4):257-9. PubMed ID: 1787550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.